RESUMO
Processes of care and adherence to guidelines have been associated with improved survival in community-acquired pneumonia (CAP). In sepsis, bundles of processes of care have also increased survival. We aimed to audit compliance with guideline-recommended processes of care and its impact on outcome in hospitalised CAP patients with sepsis. We prospectively studied 4,137 patients hospitalised with CAP in 13 hospitals. The processes of care evaluated were adherence to antibiotic prescription guidelines, first dose within 6 h and oxygen assessment. Outcome measures were mortality and length of stay (LOS). Oxygen assessment was measured in 3,745 (90.5%) patients; 3,024 (73.1%) patients received antibiotics according to guidelines and 3,053 (73.8%) received antibiotics within 6 h. In CAP patients with sepsis, the strongest independent factor for survival was antibiotic adherence (OR 0.4). In severe sepsis, only compliance to antibiotic adherence plus first dose within 6 h was associated with lower mortality (OR 0.60), adjusted for fine prognostic scale and hospital. Antibiotic adherence was related to shorter hospital stay. In sepsis, antibiotic adherence is the strongest protective factor of care associated with survival and LOS. In severe sepsis, combined antibiotic adherence and first dose within 6 h may reduce mortality.
Assuntos
Pneumonia/mortalidade , Pneumonia/terapia , Pneumologia/métodos , Sepse/mortalidade , Sepse/terapia , Adulto , Idoso , Antibacterianos/uso terapêutico , Feminino , Fidelidade a Diretrizes , Hospitalização , Humanos , Tempo de Internação , Masculino , Adesão à Medicação , Pessoa de Meia-Idade , Oxigênio/metabolismo , Estudos Prospectivos , Fatores de Tempo , Resultado do TratamentoRESUMO
To examine the association between MVP and Idiopathic Sudden Sensorineural Hearing loss (ISSNHL). 349 subjects, 86 with ISSNHL and 263 controls underwent a 2D-echocardiography. Patients with ISSNHL had higher rates of MVP (29.1% vs 2.7%, p<0.001), mitral leaflet thickening (15.1% vs 2.3%, p<0.001), mitral regurgitation (16.3% vs 6.5%, p=0.02) and left atrial enlargement (11.6% vs 3.8%, p=0.01). Our results support the hypothesis that MVP could be one of the etiological factors of ISSNHL.
Assuntos
Embolia/complicações , Perda Auditiva Súbita/etiologia , Prolapso da Valva Mitral/complicações , Ecocardiografia , Embolia/epidemiologia , Feminino , Seguimentos , Perda Auditiva Súbita/epidemiologia , Humanos , Incidência , Masculino , Pessoa de Meia-Idade , Prolapso da Valva Mitral/diagnóstico por imagem , Prolapso da Valva Mitral/epidemiologia , Prevalência , Prognóstico , Estudos Retrospectivos , Espanha/epidemiologiaRESUMO
BACKGROUND: A study was undertaken to evaluate the clinical efficacy of the 23-valent pneumococcal polysaccharide vaccine (PPV) in immunocompetent patients with chronic obstructive pulmonary disease (COPD). METHODS: A randomised controlled trial was carried out in 596 patients with COPD of mean (SD) age 65.8 (9.7) years, 298 of whom received PPV. The main outcome was radiographically proven community acquired pneumonia (CAP) of pneumococcal or unknown aetiology after a mean period of 979 days (range 20-1454). RESULTS: There were 58 first episodes of CAP caused by pneumococcus or of unknown aetiology, 25 in the intervention group and 33 in the non-intervention group. Kaplan-Meier survival curves for CAP did not show significant differences between the intervention and non-intervention arms (log rank test = 1.15, p = 0.28) in the whole group of patients. The efficacy of PPV in all patients was 24% (95% CI -24 to 54; p = 0.333). In the subgroup aged <65 years the efficacy of PPV was 76% (95% CI 20 to 93; p = 0.013), while in those with severe functional obstruction (forced expiratory volume in 1 second <40%) it was 48% (95% CI -7 to 80; p = 0.076). In younger patients with severe airflow obstruction the efficacy was 91% (95% CI 35 to 99; p = 0.002). There were only five cases of non-bacteraemic pneumococcal CAP, all in the non-intervention group (log rank test = 5.03; p = 0.025). Multivariate analysis gave a hazard ratio for unknown and pneumococcal CAP in the vaccinated group, adjusted for age, of 0.20 (95% CI 0.06 to 0.68; p = 0.01). CONCLUSIONS: PPV is effective in preventing CAP in patients with COPD aged less than 65 years and in those with severe airflow obstruction. No differences were found among the other groups of patients with COPD.
Assuntos
Infecções Comunitárias Adquiridas/prevenção & controle , Imunocompetência/fisiologia , Infecções Pneumocócicas/prevenção & controle , Vacinas Pneumocócicas , Doença Pulmonar Obstrutiva Crônica/complicações , Adulto , Idoso , Feminino , Volume Expiratório Forçado/fisiologia , Humanos , Masculino , Pessoa de Meia-Idade , Estudos Prospectivos , Streptococcus pneumoniae , Análise de Sobrevida , Resultado do TratamentoAssuntos
Antibacterianos/uso terapêutico , Infecções Comunitárias Adquiridas , Bactérias Gram-Negativas/isolamento & purificação , Bactérias Gram-Positivas/isolamento & purificação , Administração de Serviços de Saúde , Pneumonia/tratamento farmacológico , Procedimentos Cirúrgicos Torácicos/métodos , Idoso , Infecções Comunitárias Adquiridas/tratamento farmacológico , Infecções Comunitárias Adquiridas/microbiologia , Infecções Comunitárias Adquiridas/cirurgia , Humanos , Espanha , Escarro/químicaRESUMO
We present the case of a 57-year-old patient who had worked at a fiber-cement factory for 28 years. The patient developed an epithelioid-type pleural mesothelioma 5 years after retiring, after he was diagnosed with asbestosis. Only 5 months after the diagnosis of mesothelioma, a medullar section appeared to be totally invaded by a tumor in the medullar canal, thus causing paraplegia and affecting the bladder and anal sphincters. The patient underwent radiotherapy and chemotherapy, and achieved partial recovery, but died 9 months after the diagnosis.
Assuntos
Asbestose/complicações , Mesotelioma/secundário , Cuidados Paliativos/métodos , Neoplasias Pleurais/patologia , Neoplasias da Medula Espinal/secundário , Neoplasias da Coluna Vertebral/secundário , Vértebras Torácicas , Protocolos de Quimioterapia Combinada Antineoplásica/administração & dosagem , Terapia Combinada , Evolução Fatal , Humanos , Masculino , Mesotelioma/diagnóstico , Mesotelioma/etiologia , Mesotelioma/terapia , Pessoa de Meia-Idade , Neoplasias Pleurais/diagnóstico , Neoplasias Pleurais/etiologia , Neoplasias Pleurais/terapia , Pleurodese/métodos , Radioterapia/métodos , Neoplasias da Medula Espinal/diagnóstico , Neoplasias da Medula Espinal/terapia , Neoplasias da Coluna Vertebral/terapia , Tomografia Computadorizada por Raios XRESUMO
We present a phenotype-genotype correlation analysis in 12 patients with cystic fibrosis (CF) carrying the mutation R334W in the CFTR gene. The clinical data obtained for this group were compared with the clinical data of deltaF508/deltaF508 patients. Current age and age at diagnosis were significantly higher in the R334W mutation group (p=0.028 and p=0.0001). We found a lower rate of Pseudomonas aeruginosa colonisation in patients carrying the R334W mutation, although the difference was not found to be statistically significant. However, we found a statistically significant higher age of onset of Pseudomonas aeruginosa colonisation (p=0.0036) in the group of patients with the R334W mutation. Thirty three percent of R334W patients were pancreatic insufficient, significantly lower than the deltaF508/deltaF508 patients (p=0.004). We also found that the weight expressed as a percentage of ideal weight for height was significantly higher in patients with the R334W mutation (p=0.0028).
Assuntos
Regulador de Condutância Transmembrana em Fibrose Cística/genética , Fibrose Cística/genética , Mutação Puntual , Adolescente , Adulto , Idade de Início , Pré-Escolar , Fibrose Cística/complicações , Feminino , Genótipo , Humanos , Masculino , Fenótipo , Infecções por Pseudomonas/complicaçõesRESUMO
The texts of Greek comedy offer a panoramic vision of the evolution of medicine between the fifth and the third centuries. They provide an excellent way to understand the prejudices and the bases of technical medicine and its relationship with popular medicine. Comedy also shows us a vivid portrait of the physician and his position in Greek society.
Assuntos
Drama/história , História Antiga , Ciência de Laboratório Médico/história , Medicina na Literatura , Opinião Pública , Grécia Antiga , HumanosRESUMO
The aim of this prospective study was to determine the rate of recurrence for spontaneous pneumothorax (SP) after tetracycline pleurodesis (TCP), using that of observation, tube thoracostomy alone, and thoracotomy as references. From 1985 to the end of 1991, 78 patients were treated with tetracycline pleurodesis and 135 patients served as control subjects. Pleurodesis was induced by instillation of tetracycline and ascorbic acid through the pleural drain. The indication was any SP treated with tube thoracostomy, without active pulmonary infection. Follow-up period was from 13 to 95 months (mean, 45 months); follow-up rate was 94 percent. Post-therapy surgery was necessary for eight patients in whom pleurodesis failed due to presence of a persistent air leak. The ipsilateral recurrence rate of patients treated with TCP was 9 percent (6/66) and recurrence time ranged from 2 days to 9 months. The recurrence rate for patients treated with observation was 36 percent, 35 percent for those having chest tube alone, and none for those undergoing surgery. No death occurred as a direct result of this procedure and all patients could be released from the hospital. Eleven subjects died during the follow-up period; the mean follow-up until death was 37 months (range, 2 to 87 months). Five deaths were due to respiratory causes and six were due to extrapulmonary causes. Tetracycline pleurodesis has been shown to be a good alternative for the prevention of recurrence of SP. Its recurrence rate is lower than that of tube drainage but higher than that of surgical treatment.
Assuntos
Pleurodese/métodos , Pneumotórax/terapia , Tetraciclina/administração & dosagem , Adolescente , Adulto , Idoso , Idoso de 80 Anos ou mais , Ácido Ascórbico/administração & dosagem , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Pneumotórax/mortalidade , Pneumotórax/prevenção & controle , Estudos Prospectivos , Recidiva , Toracostomia , Toracotomia , Resultado do TratamentoRESUMO
The etiology, microbiologic findings, and management of 82 episodes of empyema treated by our unit over a period of 6 years were analyzed. Average patient age was 54 years. Eighty-two percent had underlying disease such as alcoholism (29 percent), malignancy (23 percent), and diabetes mellitus (20 percent). Sixty (73 percent) had an empyema develop secondary to a bronchopulmonary infection. Other etiologies were as follows: infradiaphragmatic sepsis, five cases; iatrogenic, ten cases; and idiopathic, seven cases. Cultures were positive in 76 cases and negative in the remaining 6 (2 positive Gram stains, 1 positive under bacilloscopy, and 3 were sterile). Anaerobes were isolated from 25 and aerobes from 47 of the positive cultures. A single bacteria was isolated from 43 and multiple organisms (average: 2.63/case) grew on the remaining 33 positive cultures. Length of hospitalization averaged 37 days. Seven patients received antibiotics only, thoracentesis was performed on three, intercostal chest tube drainage was required in 72, and more aggressive surgery was performed on 12 patients (7 with fibrothorax and 5 with pneumonectomy). Streptokinase was instilled into the pleural space of eight patients with good results. Pleural drainage superinfection occurred at a rate of 8.5 percent. Nine patients died; the remaining recovered. Only three deaths came about as a direct result of the empyema.